How Moonrise Medical is scaling its vascular imaging solution
30 June 2026
Learn how Moonrise Medical is leveraging the CAMEDA program to scale its AI vascular imaging platform and accelerate its path to market.
Tag: Success Stories
Using biological processes to effectively target cancer and infectious disease with Esphera SynBio
17 February 2026
Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.
Recent awards power two new studies into drug discovery and development
24 November 2025
Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.
Leading the new era of AI-driven drug discovery with Stoked Bio
19 November 2025
Discover how Stoked Bio is leveraging resources like the SOPHIE program to advance AI-driven drug discovery.
Advancing Stroke Rehabilitation with IRegained’s MyHand® System
23 October 2025
Explore how IRegained leveraged resources like the CAMEDA program to advance their MyHand® System for stroke rehabilitation
Improving patient recovery with FluidAI’s postoperative monitoring solution
23 July 2024
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Healing chronic wounds with Swift Medical
16 May 2024
Learn how Swift Medical is reshaping the way wounds are imaged for diagnosis with AI and data-driven technology.
Synmedix: Treating infections with the next generation of antibiotics
21 February 2024
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
From ideation to commercialization, Cosm’s journey in advancing women’s pelvic health as it enters the Canadian market and beyond!
3 November 2023
Femtech startup Cosm Medical is changing women’s pelvic health with a medical device that combines software, AI and 3D printing.
Epineuron’s efforts to create a pain free world from peripheral nerve damage supported by Hamilton’s life science ecosystem
25 August 2023
Discover how the SOPHIE program guided Epineuron Technologies’ efforts towards a pain-free future for people with peripheral nerve damage.
EmergConnect is Transforming Access to Healthcare with the Support of Hamilton’s Life Science Ecosystem
18 May 2023
The EmergConnect platform is transforming access to healthcare for Canadians with support from the SOPHIE program.
Evolving a Novel Approach to Cell-Based Therapies with Hamilton’s Renowned Medical Innovation Ecosystem
30 January 2023
Allarta Life Science leverages the SOPHIE program with the goal of licensing technology and commercializing treatments.
Recent news
How Moonrise Medical is scaling its vascular imaging solution
30 June 2026
Learn how Moonrise Medical is leveraging the CAMEDA program to scale its AI vascular imaging platform and accelerate its path to market.
Using biological processes to effectively target cancer and infectious disease with Esphera SynBio
17 February 2026
Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.
Recent awards power two new studies into drug discovery and development
24 November 2025
Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.
Client success stories
How Moonrise Medical is scaling its vascular imaging solution
30 June 2026
Learn how Moonrise Medical is leveraging the CAMEDA program to scale its AI vascular imaging platform and accelerate its path to market.
Using biological processes to effectively target cancer and infectious disease with Esphera SynBio
17 February 2026
Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.
Recent awards power two new studies into drug discovery and development
24 November 2025
Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.
Press releases
Innovation Factory’s SOPHIE Program secures three-year renewal with $5.2M investment
27 September 2024
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Innovation Factory fosters life science success stories in Ontario through SOPHIE program
17 July 2024
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
Innovation Factory celebrates Hamilton’s growing life sciences network and SOPHIE program recipients
23 November 2023
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Subscribe to our newsletter for updates!
Client success stories
Leading the new era of AI-driven drug discovery with Stoked Bio
19 November 2025
Advancing Stroke Rehabilitation with IRegained’s MyHand® System
23 October 2025